JACC. Case reports · 2025
Stellate Ganglion Block to Increase Defibrillation Effectiveness in Acute Fulminant Myocarditis-Induced Refractory Ventricular Fibrillation.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Morena Arianna, Gravinese Carol, Frea Simone, Angelini Filippo, Saglietto Andrea, Zanierato Marinella, Andriani Monica, Scacciatella Paolo, De Ferrari Gaetano Maria, Dusi Veronica
Аннотация
BACKGROUND: Percutaneous left stellate ganglion block (PLSGB) is used to prevent ventricular arrhythmia recurrences in various settings. Clinical data on its impact on ventricular fibrillation (VF) defibrillation threshold are scant and limited to acute coronary syndromes.
CASE SUMMARY: We present a case of refractory VF in acute fulminant myocarditis. Despite multiple drugs and hemodynamic mechanical support, the VF was unresponsive to several DC shock attempts, including double sequential and vector change defibrillation. PLSGB allowed stable sinus rhythm restoration.
DISCUSSION: PLSGB was performed to enhance the success of DC shock, highlighting the importance of acute neuromodulation strategies not only to prevent ventricular arrhythmia recurrences but also to improve defibrillation effectiveness. Our case is the first reported PLSGB usage in acute fulminant myocarditis-induced refractory VF.
CASE SUMMARY: We present a case of refractory VF in acute fulminant myocarditis. Despite multiple drugs and hemodynamic mechanical support, the VF was unresponsive to several DC shock attempts, including double sequential and vector change defibrillation. PLSGB allowed stable sinus rhythm restoration.
DISCUSSION: PLSGB was performed to enhance the success of DC shock, highlighting the importance of acute neuromodulation strategies not only to prevent ventricular arrhythmia recurrences but also to improve defibrillation effectiveness. Our case is the first reported PLSGB usage in acute fulminant myocarditis-induced refractory VF.